ABLBio Stock Analysis: Current Price and Valuation Insights
ABL Bio’s share price is KRW 178,800 with a market cap of KRW 9.8 trillion, reflecting a substantial 500% annual return. Despite a significant Q3 revenue decline, future expectations hinge on recent partnerships with GSK and Lilly. The company’s high valuation and volatile stock pattern pose risks, urging cautious investment strategies.